As of Jan. 8, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 150 points on Monday.
Shares of Harpoon Therapeutics, Inc.(NASDAQ: HARP) rose sharply in pre-market trading. Bloomberg reported that Merck is in advanced talks to buy Harpoon Therapeutics for $23 per share.
Several major investors are reportedly advocating for BP (NYSE: BP) to consider appointing an external candidate as its CEO, marking a potential departure from the company's tradition of
A newly published study in the Journal of Cancer Survivorship has shown the prevalence and motivations behind cannabis use among individuals who have battled cancer.